CAITLIN COLESCOTT: Open Payments
NPI 1114635182 · SAINT JOSEPH, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,335 in 70 payments from 16 companies in 2025. Trend: 2023 $542 · 2024 $374 · 2025 $1,335
Food & beverage: $1,335
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $242 |
| Vanda Pharmaceuticals Inc. | 7 | $205 |
| ABBVIE INC. | 11 | $141 |
| Otsuka America Pharmaceutical, Inc. | 6 | $129 |
| ViiV Healthcare Company | 7 | $122 |
| Lilly USA, LLC | 7 | $102 |
| Amgen Inc. | 4 | $67 |
| Astellas Pharma US Inc | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Lundbeck LLC | 2 | $43 |
Products named: REXULTI, FANAPT, FARXIGA, VRAYLAR, MOUNJARO, OTEZLA, Veozah, HETLIOZ.
Industry payments across MO — which companies pay providers there.
